Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02308163
What this trial is testing

Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 509
Large-scale testing (Phase 3)Study completedNCT02011334
What this trial is testing

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 285
Large-scale testing (Phase 3)Study completedNCT01844895
What this trial is testing

Methotrexate-Inadequate Response Autoinjector Device Sub Study

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 120
Testing effectiveness (Phase 2)Study completedNCT02805439
What this trial is testing

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
Institut de Recherches Internationales Servier 400
Testing effectiveness (Phase 2)Study completedNCT00913432
What this trial is testing

Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AB Science 20
Testing effectiveness (Phase 2)Study completedNCT02015520
What this trial is testing

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
CSL Behring 143
Post-approval studies (Phase 4)Study completedNCT00764725
What this trial is testing

Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)

Who this might be right for
Rheumatoid Arthritis
Karolinska Institutet 487
Large-scale testing (Phase 3)Study completedNCT02085135
What this trial is testing

Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 66
Large-scale testing (Phase 3)Study completedNCT01197508
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

Who this might be right for
Major Depressive Disorder
AstraZeneca 696
Large-scale testing (Phase 3)Study completedNCT01987479
What this trial is testing

A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 150
Post-approval studies (Phase 4)WithdrawnNCT01878318
What this trial is testing

The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT02955212
What this trial is testing

A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 338
Testing effectiveness (Phase 2)WithdrawnNCT02097264
What this trial is testing

A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S
Large-scale testing (Phase 3)Study completedNCT02720198
What this trial is testing

Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD

Who this might be right for
Major Depressive Disorder
Duke University 60
Early research (Phase 1)WithdrawnNCT01559831
What this trial is testing

Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH
Large-scale testing (Phase 3)Study completedNCT01566292
What this trial is testing

Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy

Who this might be right for
Benign Prostatic Hyperplasia (BPH)Benign Prostatic Enlargement (BPE)
Catholic University of the Sacred Heart 33
Large-scale testing (Phase 3)Study completedNCT01245439
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 65
Large-scale testing (Phase 3)Study completedNCT02097745
What this trial is testing

The Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 341
Large-scale testing (Phase 3)Study completedNCT01091675
What this trial is testing

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Who this might be right for
Ankylosing Spondylitis
Spanish Foundation of Rheumatology 58
Not applicableActive Not RecruitingNCT05936970
What this trial is testing

Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD

Who this might be right for
Rheumatoid Arthritis
Aqtual, Inc. 1,410
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation